Yousefi S, Vaziri N, Carandang G, Villanueva J L, Khonsari S, Ocariz J, Cesario T C
Department of Medicine and Pathology, University of California, Irvine, USA.
J Interferon Cytokine Res. 1997 Feb;17(2):107-12. doi: 10.1089/jir.1997.17.107.
Platelet-activating factor (PAF) was tested for its ability to alter yields of human interferon (IFN) produced from peripheral blood mononuclear cells (PBMC). Using different concentrations of phytohemagglutinin (PHA) we could not demonstrate a consistent effect of PAF at any concentration tested on the yield of IFN-gamma. Similarly, although PAF was associated with a slight enhancement of IFN-gamma yields when PBMC were induced by interleukin-2 (IL-2), the results were not statistically significant. No effect was observed on the accumulation of human IFN-gamma mRNA induced by PHA. Furthermore, PAF did not enhance yields of IFN-gamma when the cells were induced by poly I:poly C. We conclude that although PAF may have a role in sepsis, it is not likely that this is in any way related to its ability to significantly alter the yield of interferons.
对血小板活化因子(PAF)改变外周血单个核细胞(PBMC)产生的人干扰素(IFN)产量的能力进行了测试。使用不同浓度的植物血凝素(PHA),我们未能证明在任何测试浓度下PAF对γ干扰素产量有一致的影响。同样,虽然当PBMC由白细胞介素-2(IL-2)诱导时,PAF与γ干扰素产量的轻微增加有关,但结果无统计学意义。未观察到PAF对PHA诱导的人γ干扰素mRNA积累有影响。此外,当细胞由聚肌苷酸:聚胞苷酸(poly I:poly C)诱导时,PAF并未提高γ干扰素产量。我们得出结论,虽然PAF可能在脓毒症中起作用,但这很可能与它显著改变干扰素产量的能力毫无关系。